These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 27004972)

  • 61. BRAF, NRAS, KIT, TERT, GNAQ/GNA11 Mutation Profile and Histomorphological Analysis of Anorectal Melanomas: A Clinicopathologic Study.
    Taskin OC; Sari SO; Yilmaz I; Hurdogan O; Keskin M; Buyukbabani N; Gulluoglu M
    Turk Patoloji Derg; 2023; 39(1):23-30. PubMed ID: 35642348
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Gynecologic melanomas: A clinicopathologic and molecular analysis.
    Udager AM; Frisch NK; Hong LJ; Stasenko M; Johnston CM; Liu JR; Chan MP; Harms PW; Fullen DR; Orsini A; Thomas DG; Lowe L; Patel RM
    Gynecol Oncol; 2017 Nov; 147(2):351-357. PubMed ID: 28844540
    [TBL] [Abstract][Full Text] [Related]  

  • 63. BRAF/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damage.
    Mar VJ; Wong SQ; Li J; Scolyer RA; McLean C; Papenfuss AT; Tothill RW; Kakavand H; Mann GJ; Thompson JF; Behren A; Cebon JS; Wolfe R; Kelly JW; Dobrovic A; McArthur GA
    Clin Cancer Res; 2013 Sep; 19(17):4589-98. PubMed ID: 23833303
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Primary mucosal desmoplastic melanoma of the head and neck.
    Prasad ML; Patel SG; Busam KJ
    Head Neck; 2004 Apr; 26(4):373-7. PubMed ID: 15054741
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Conjunctival Melanoma: Genetic and Epigenetic Insights of a Distinct Type of Melanoma.
    Rossi E; Schinzari G; Maiorano BA; Pagliara MM; Di Stefani A; Bria E; Peris K; Blasi MA; Tortora G
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31683701
    [TBL] [Abstract][Full Text] [Related]  

  • 66. TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma.
    Griewank KG; Murali R; Puig-Butille JA; Schilling B; Livingstone E; Potrony M; Carrera C; Schimming T; Möller I; Schwamborn M; Sucker A; Hillen U; Badenas C; Malvehy J; Zimmer L; Scherag A; Puig S; Schadendorf D
    J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25217772
    [TBL] [Abstract][Full Text] [Related]  

  • 67. NRAS and BRAF mutations in cutaneous melanoma and the association with MC1R genotype: findings from Spanish and Austrian populations.
    Hacker E; Nagore E; Cerroni L; Woods SL; Hayward NK; Chapman B; Montgomery GW; Soyer HP; Whiteman DC
    J Invest Dermatol; 2013 Apr; 133(4):1027-33. PubMed ID: 23096702
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Melanoma.
    Schadendorf D; Fisher DE; Garbe C; Gershenwald JE; Grob JJ; Halpern A; Herlyn M; Marchetti MA; McArthur G; Ribas A; Roesch A; Hauschild A
    Nat Rev Dis Primers; 2015 Apr; 1():15003. PubMed ID: 27188223
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Molecular Profile of Subungual Melanoma: A MelaNostrum Consortium Study of 68 Cases Reporting BRAF, NRAS, KIT, and TERT Promoter Status.
    Millan-Esteban D; García-Casado Z; Macià A; de la Rosa I; Torrecilla-Vall-Llossera C; Penin RM; Manrique-Silva E; Pellegrini S; Biasin MR; Rizzolo P; Gavillero A; Di Stefani A; Pellegrini C; Requena C; Fargnoli MC; Peris K; Cota C; Menin C; Landi MT; Nagore E
    Dermatology; 2024; 240(1):164-169. PubMed ID: 37918362
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prevalence of BRAF and NRAS mutations in fast-growing melanomas.
    Nagore E; Hacker E; Martorell-Calatayud A; Traves V; Guillen C; Hayward NK; Whiteman D
    Pigment Cell Melanoma Res; 2013 May; 26(3):429-31. PubMed ID: 23448684
    [No Abstract]   [Full Text] [Related]  

  • 71. [Mucosal melanomas of the head and neck: State of the art and current controversies].
    Troussier I; Baglin AC; Marcy PY; Even C; Moya-Plana A; Krengli M; Thariat J
    Bull Cancer; 2015 Jun; 102(6):559-67. PubMed ID: 26022288
    [TBL] [Abstract][Full Text] [Related]  

  • 72. BRAF mutations in conjunctival melanoma.
    Gear H; Williams H; Kemp EG; Roberts F
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2484-8. PubMed ID: 15277467
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Lack of hotspot mutations in BRAF, NRAS, and KIT genes in primary meningeal melanocytic tumors of intermediate grade.
    Kim YJ; Müller CS; Bohle RM
    Clin Neuropathol; 2016; 35(3):151-3. PubMed ID: 26784966
    [No Abstract]   [Full Text] [Related]  

  • 74. Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis.
    Willmore-Payne C; Holden JA; Tripp S; Layfield LJ
    Hum Pathol; 2005 May; 36(5):486-93. PubMed ID: 15948115
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Assessment of clinical parameters associated with mutational status in metastatic malignant melanoma: a single-centre investigation of 141 patients.
    Schlaak M; Bajah A; Podewski T; Kreuzberg N; von Bartenwerffer W; Wardelmann E; Merkelbach-Bruse S; Büttner R; Mauch C; Kurschat P
    Br J Dermatol; 2013 Apr; 168(4):708-16. PubMed ID: 23528057
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Conjunctival Melanoma: Current Treatments and Future Options.
    Grimes JM; Shah NV; Samie FH; Carvajal RD; Marr BP
    Am J Clin Dermatol; 2020 Jun; 21(3):371-381. PubMed ID: 31965542
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Molecular Genetics of Conjunctival Melanoma and Prognostic Value of
    van Poppelen NM; van Ipenburg JA; van den Bosch Q; Vaarwater J; Brands T; Eussen B; Magielsen F; Dubbink HJ; Paridaens D; Brosens E; Naus N; de Klein A; Kiliç E; Verdijk RM
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071371
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparative analysis of BRAF, NRAS and c-KIT mutation status between tumor tissues and autologous tumor cell-lines of stage III/IV melanoma.
    Knol AC; Pandolfino MC; Vallée A; Nguyen F; Lella V; Khammari A; Denis M; Puaux AL; Dréno B
    Exp Dermatol; 2015 Jan; 24(1):70-3. PubMed ID: 25363723
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sinonasal mucosal melanoma: Molecular profile and therapeutic implications from a series of 32 cases.
    Turri-Zanoni M; Medicina D; Lombardi D; Ungari M; Balzarini P; Rossini C; Pellegrini W; Battaglia P; Capella C; Castelnuovo P; Palmedo G; Facchetti F; Kutzner H; Nicolai P; Vermi W
    Head Neck; 2013 Aug; 35(8):1066-77. PubMed ID: 22791410
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical and pathological associations of the activating RAC1 P29S mutation in primary cutaneous melanoma.
    Mar VJ; Wong SQ; Logan A; Nguyen T; Cebon J; Kelly JW; Wolfe R; Dobrovic A; McLean C; McArthur GA
    Pigment Cell Melanoma Res; 2014 Nov; 27(6):1117-25. PubMed ID: 25043693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.